DEADLINE FOR RECEIPT OF ABSTRACTS:
MARCH 31, 2010
Please note the following instructions
for the preparation of abstracts:
- Abstracts must be written
and should be structured in such a way as to include: Objectives,
background, methods and results and conclusions.
- All abbreviations must be defined
before being used as an abbreviation in the text.
- The content of the abstract is
solely the responsibility of the author. The original abstract is
reprinted exactly as provided. It is therefore essential that the
abstract is correctly typed. Avoid errors, corrections and
- Abstracts should contain no more
than 250 words (1800 characters) of text in the recommended font:
Times New Roman, size 11 pts. Do NOT use a smaller font size.
- Use single spacing.
- Title should be typed in UPPER
CASE letters in bold and not exceed more than 100 characters.
Titles with more than 100 characters will be truncated.
- The author/s names and
institution/s should be in upper and lower case.
- Please clearly indicate the name
of the presenting author, who will be considered the contact
person for all correspondence connected with this abstract.
- No endnotes or frames are
- Abstracts sent by fax will not be
processed by the Secretariat and will not be forwarded to the
Scientific Committee for review.
- Symbols, tables, graphs or pictures cannot be submitted via the website. Abstracts containing symbols, tables, graphs or pictures must be emailed as an attachment saved as a Word document to the Congress Secretariat: email@example.com. Include the presenting author's full contact details as well as the category under which your abstract should be reviewed.
The International Academy of Cardiology requires that audiences at
the Academy's educational programs be informed of a presenter's
(moderators, speakers, faculty, authors and contributors) academic
and professional affiliations, as well as other commercial
relationships relevant to the content of the material that is
The policy allows the listener/attendee to be fully informed in
evaluating the information being presented. The situations may
include, but are not limited to 1) stock options or bond holdings in
a for-profit corporation or self-directed pension plan, 2) research
grants, 3) employment (full or part time), 4) ownership or
partnership, 5) consulting fees or other remuneration received by
the presenter or his/her immediate family, including support that
may be provided to attend the educational meeting, 6)
nonremunerative positions of influence such as officer, board
member, trustee, or public spokesperson. The disclosure will be
shown as an indication (by an *) for those presenters who have
stated that a relationship(s) exists relevant to the topic(s) being
Indicate any author(s) who has a
possible conflict of interest (see policy statement) by an asterisk
(*) next to that author(s) name in the heading of the abstract.
Abstract(s) may be submitted via this